Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-01 Hassanein Waleed H President & CEO Sale −5,546 $71.44 $396K 553,645
2023-06-01 Hassanein Waleed H President & CEO Sale −1,954 $72.21 $141K 551,691
2023-05-25 KANIA EDWIN M JR Director Grant or award +1,193 257,944
2023-05-25 KANIA EDWIN M JR Director Grant or award · Stock Option (Right to Buy) +1,916 1,916
2023-05-25 TOBIN JAMES R Director Grant or award +1,193 1,193
2023-05-25 TOBIN JAMES R Director Grant or award · Stock Option (Right to Buy) +1,916 1,916
2023-05-25 RAINES MERILEE Director Grant or award +1,193 1,193
2023-05-25 RAINES MERILEE Director Grant or award · Stock Option (Right to Buy) +1,916 1,916
2023-05-25 Gunderson Thomas James Director Grant or award +1,193 1,193
2023-05-25 Gunderson Thomas James Director Grant or award · Stock Option (Right to Buy) +1,916 1,916
2023-05-25 Basile Edward M Director Grant or award +1,193 15,507
2023-05-25 Basile Edward M Director Grant or award · Stock Option (Right to Buy) +1,916 1,916
2023-05-25 Weill David Director Grant or award +1,193 11,193
2023-05-25 Weill David Director Grant or award · Stock Option (Right to Buy) +1,916 1,916
2023-05-25 Lovell Stephanie Director Grant or award +1,193 1,193
2023-05-25 Lovell Stephanie Director Grant or award · Stock Option (Right to Buy) +1,916 1,916
2023-05-01 Gordon Stephen Chief Financial Officer Exercise or conversion +5,000 $16.14 $81K 23,789
2023-05-01 Gordon Stephen Chief Financial Officer Sale −5,000 $79.05 $395K 18,789
2023-05-01 Gordon Stephen Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −5,000 10,728
2023-05-01 Hassanein Waleed H President & CEO Sale −5,406 $77.84 $421K 561,285

Page 25 of 38 · 744 trades